Call to arrange a consultation
+1 416 777 0888
Search the site
Bayer Inc. et al v. Sandoz Canada Inc.
2025
T-239-25
Resolved
8.2 PM(NOC) Regulations
Action under section 8.2 of the Patented Medicines (Notice of Compliance) Regulations regarding aflibercept.
Counsel to:
Sandoz Canada Inc.
The decision is reported
here.
Meet the team.
.jpg)
.jpg)
%20(1).jpg)
